CERo Therapeutics Hldgs Stock (NASDAQ: CERO) stock price, news, charts, stock research, profile.
You can purchase shares of CERo Therapeutics Hldgs (NASDAQ:CERO) through any online brokerage.
Other companies in CERo Therapeutics Hldgs’s space includes: Vincerx Pharma (NASDAQ:VINC), Immuron (NASDAQ:IMRN), Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN) and T2 Biosystems (NASDAQ:TTOO).
There is no analysis for CERo Therapeutics Hldgs to provide a consensus price target.
The stock price for CERo Therapeutics Hldgs (NASDAQ: CERO) is $0.04935 last updated December 23, 2024 at 7:59 PM EST.
There are no upcoming dividends for CERo Therapeutics Hldgs.
CERo Therapeutics Hldgs’s Q4 earnings are confirmed for Thursday, February 20, 2025.
There is no upcoming split for CERo Therapeutics Hldgs.
CERo Therapeutics Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.